Program Agenda May 3, 2008, Washington, DC 7 AM to 8 AM - Registration and Continental Breakfast 8:00 AM Introduction and Overview Co-Chairs: Jeffrey Cummings, MD, and Pierre N. Tariot, MD Educational Session 1: Advances in Clinical Assessment 8:30 AM What Are the Short Clinical Assessments Applicable to Busy Practices? 9:00 AM Neuropsychological Characterization of Dementia Patients: When is It Helpful? 9:30 AM Computerized Neuropsychological Assessments: Ready for Prime Time? 10:00 AM Break Ziad Nassredine, MD Kathleen Welsh-Bohmer, PhD Ellen Woo, PhD Educational Session 2: Advances in Neuroimaging and Biomarkers 10:30 AM Use of MRI to Identify MCI: Who Should be Imaged? 11:00 AM FDG and Amyloid PET: What Information do These Provide? 11:30 AM CSF: When is It Worthwhile to do an LP? 12:00 PM Lunch 1:00 PM Afternoon Introduction — Symptomatic- and Disease-Modifying Treatments: How Will They Be Integrated? Liana Apostolova, MD Mark A. Mintun, MD Elaine Peskind, MD Jeffrey Cummings, MD Educational Session 3: Current AD Therapy: Best Practices 1:30 PM Beyond Standard Anti-Dementia Therapies: Diet, Exercise, Socialization, and Supplements 2:00 PM Cholinesterase Inhibitors and Memantine: What are the Best Practices? 2:30 PM Break Gary W. Small, MD Rachelle Doody, MD, PhD Educational Session 4: The Future of AD Therapeutics 3:00 PM Amyloid-based Therapeutics: How do the Basic Science Findings Translate to Novel Treatments? 3:30 PM Immunuotherapy for AD: Where are We Now? 4:00 PM Neuroprotection: What are the Non-Amyloid Approaches? Paul S. Aisen, MD Norman R. Relkin, MD, PhD Mary Sano, PhD Panel Discussion 4:30 PM Russell Katz, MD, Director of Neurology Products, FDA; Faculty and Audience Participation 5:15 PM End of Panel Discussion Moderators: Jeffrey Cummings, MD, and Pierre N. Tariot, MD Cocktail Reception 5:30-7:00 PM Meet the Faculty
®Copyright 2007-2008, Alzheimer's Disease Summit. All Rights Reserved.